MyHealthChecked PLC

Equities

FRI

GB00BN7K5L93

Advanced Medical Equipment & Technology

Market Closed - London S.E. 11:35:00 2024-04-26 am EDT 5-day change 1st Jan Change
10 GBX 0.00% Intraday chart for MyHealthChecked PLC -6.98% -24.53%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
MyHealthChecked expects 2023 earnings breakeven AN
MyHealthChecked PLC Provides Revenue Guidance for the Full Year 2023 CI
Maintel outlook promising; Good Energy revenue up AN
Earnings Flash (MHC.L) MYHEALTHCHECKED Posts H1 Revenue GBP2.5M MT
Earnings Flash (MHC.L) MYHEALTHCHECKED Posts H1 Loss GBX-0.61 MT
MyHealthChecked PLC Reports Earnings Results for the Half Year Ended June 30, 2023 CI
FTSE 100 Closes Down as Investors Driven into Risk-Off Mood DJ
Stocks slide as weak Chinese data lowers mood AN
Sterling Likely to Fall in Longer Run as Markets Overestimate Rate Prospects DJ
FTSE 100 down on China growth worries AN
FTSE 100 Edges Lower as Miners Fall After Weak China Trade Data, Glencore Earnings DJ
AIM WINNERS & LOSERS: PHSC up on swing to profit; MyHealthChecked down AN
MyHealthChecked shares drop as revenue falls; Covid test demand down AN
FTSE 100 Closes Down 0.2% as Miners Offset Ocado, Rolls-Royce Jumps DJ
MyHealthChecked CFO Edwards to leave at end of month AN
MyHealthChecked CFO to Step Down MT
Myhealthchecked plc Announces CFO Changes CI
MyHealthChecked PLC Appoints Amber Vodegel as A Non-Executive Director, with Effect from 3 July 2023 CI
Yourgene to process tests at lab as part of MyHealthChecked Boots deal AN
MyHealthChecked Shares Zoom Up 19% Amid Boots UK Sales Deal MT
Stocks and dollar up on US debt ceiling optimism AN
AIM WINNERS & LOSERS: MyHealthChecked to sell tests at Boots shops AN
MyHealthChecked well-positioned to deliver further success in 2023 AN
MyHealthChecked yet to agree formal product retail deal AN
MyHealthChecked registers with Welsh healthcare watchdog AN
Chart MyHealthChecked PLC
More charts
MyHealthChecked PLC is a United Kingdom-based consumer home-testing healthcare company. The Company is the umbrella brand of a range of at-home rapid tests, as well as deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and blood sample collection kits. The Company also provides COVID tests. The Company's multi-platform portfolio of tests offers users access to a variety of test types, sample collection options, and levels of analysis, enabling it to meet diverse customer needs. The tests are lateral-flow self-tests, whilst the sample collection kits enable the collection of blood, urine, nasal or mouth swab samples that are analyzed in partner laboratories for a range of biomarkers. The tests have been made available online and for over-the-counter purchase. All its business activity is underpinned by two distinct routes to market: business to business to consumer (B2B2C) and direct to consumer.
More about the company

Annual profits - Rate of surprise